Kristin Fabre,
Deputy Chief Scientist, NASA Human Research Program
Dr. Fabre joined the NASA Human Research Program as Deputy Chief Scientist in January of 2022. In this role, she works with the HRP Management Team and HRP Scientists to help drive scientific strategy and scientific portfolio management; working toward the mission of investing in research and technology that mitigates human risk during spaceflight and space missions. Dr. Fabre’s previous role was as Chief Scientist at the Translational Research Institute for Space Health from December 2018 to May 2020. At TRISH she led TRISH’s effort to invest in high-risk, high-reward research and technology for space exploration. She worked with various stakeholders including NASA, industry and academia to adopt and implement outcomes from TRISH-funded project deliverables. Before joining TRISH, Dr. Fabre was the Microphysiological Systems (MPS) Lead at AstraZeneca and was part of the MPS Center of Excellence, Drug Safety and Metabolism. Prior to joining AZ in 2016, she was the Scientific Program Manager for the Microphysiological Systems (or Organs-on-Chips) Initiative at NIH National Center for Advancing Translational Sciences (NCATS).
Dr. Fabre received her BS in Biology from the University of Wyoming, followed by her MS and PhD from Colorado State University in Cell and Molecular Biology. Prior to joining NCATS, she was at the NIH National Cancer Institute as a postdoctoral fellow in the Radiation Biology Branch. During her time at the NCI, Dr. Fabre was highly involved with training programs and was Chair of the NCI Fellows and Young Investigators Steering Committee and created the NCI Fellows Outreach Committee.
|
|
|
